Low Measles Seropositivity in Vaccinated Children
- Huy Quang Quach 1, Sara P Jones 2, Iype Joseph 2, Alexandria J Powell 1, Inna G Ovsyannikova 1, Nathaniel D Warner 3, Diane E Grill 3, John B Johnson 2, Remya Vasanthi Sasi 2, Archana Mohankumar Ajithakumari 2, Raji Prasad 2, Remya Reveendran 2, Jayalekshmi Devakikutty 2, Vishnu Vikraman Mohanakumari 2, Gregory A Poland 1, M Radhakrishna Pillai 2, Joshy Jacob 4, Richard B Kennedy 1
- Huy Quang Quach 1, Sara P Jones 2, Iype Joseph 2
- 1Mayo Clinic Vaccine Research Group, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
- 2Pathogen Biology, BRIC-Rajiv Gandhi Centre for Biotechnology (BRIC-RGCB), Jagathy, Thiruvananthapuram 695014, Kerala, India.
- 3Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.
- 4Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia.
- 0Mayo Clinic Vaccine Research Group, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Despite high measles vaccination rates in Indian children, significant immunity gaps and breakthrough infections persist, challenging elimination goals. Further research is needed to address suboptimal vaccine responses and strengthen immunization programs.
Area Of Science
- Immunology
- Vaccinology
- Public Health
Background
- India's measles elimination goal is hindered by ongoing outbreaks.
- High measles vaccine coverage does not always translate to complete population immunity.
Purpose Of The Study
- To determine measles seroprevalence in vaccinated Indian children.
- To investigate demographic factors influencing measles antibody responses.
- To identify potential gaps in vaccine-induced immunity.
Main Methods
- A cross-sectional study of 684 vaccinated children and 544 mothers in Kerala and Tamil Nadu (2018-2023).
- Quantification of measles-specific immunoglobulin G (IgG), neutralizing antibodies, and IgM in serum samples.
- Analysis of demographic factors and vaccine doses in relation to antibody titers.
Main Results
- 90.8% of children had positive measles-specific IgG and 91.5% had protective neutralizing antibodies.
- Female children showed higher antibody titers than males; titers were stable over time and not dose-dependent in children.
- Differential measles-specific IgM profiles in siblings suggested breakthrough infections despite high IgG and neutralizing antibody levels.
Conclusions
- Substantial measles immunity gaps exist in highly vaccinated Indian children, indicating breakthrough infections.
- These findings challenge India's measles elimination efforts and highlight the need to strengthen the immunization program.
- Addressing suboptimal immune responses to measles vaccination is crucial for achieving elimination goals beyond simply increasing vaccine coverage.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
01:51
Overview
Vaccination is the administration of antigenic material from pathogens to confer immunity against a specific microorganism. Vaccination primes the immune system to recognize and mount an immune response faster and more effectively if the real pathogen is encountered. Vaccinations are one of the most efficient ways to protect both individual humans and the general public from disease. A growing anti-vaccination skepticism risks the successes of vaccination programs that helped reduce...
00:42
Overview
The ability of a single antibody to recognize multiple structurally similar epitopes is an important immune defense strategy that enables the host to efficiently defend against many potentially threatening pathogens. However, cross-reactivity also elicits allergy symptoms against related allergens. It is increasingly important to understand the principles of cross-reactivity, as antibodies are actively being developed as therapeutic modalities for diverse diseases, including cancer.

